StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3066% below fair value
$12.20+0.01 (+0.08%)

Close on Nov 18, 2026Market cap $136.43MP/E –Yield 0.00%

Medifast net income

Net income is the profit left for shareholders after every expense, interest and tax.

Medifast's net income for the twelve months ending Sep 30, 2026 was -$40.85M, down 16572.6% year over year. For fiscal 2025 it was -$18.67M, down 993.0% from the year before. The highest annual figure on record is $164.03M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.67M-993.0%
FY2024Dec 31, 2024$2.09M-97.9%
FY2023Dec 31, 2023$99.42M-30.8%
FY2022Dec 31, 2022$143.57M-12.5%
FY2021Dec 31, 2021$164.03M+59.5%
FY2020Dec 31, 2020$102.86M+32.0%
FY2019Dec 31, 2019$77.92M+39.7%
FY2018Dec 31, 2018$55.79M+101.3%
FY2017Dec 31, 2017$27.72M+55.4%
FY2016Dec 31, 2016$17.84M-11.1%
FY2015Dec 31, 2015$20.06M+52.2%
FY2014Dec 31, 2014$13.18M-45.0%
FY2013Dec 31, 2013$23.97M+51.0%
FY2012Dec 31, 2012$15.88M-14.4%
FY2011Dec 31, 2011$18.54M-5.5%
FY2010Dec 31, 2010$19.61M+72.7%
FY2009Dec 31, 2009$11.36M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$17.51M–
Q2 FY2026Jun 30, 2026-$3.10M-225.0%
Q1 FY2026Mar 31, 2026-$2.12M–
Q4 FY2025Dec 31, 2025-$18.12M-2362.0%
Q3 FY2025Sep 30, 2025-$2.26M-300.3%
Q2 FY2025Jun 30, 2025$2.48M–
Q1 FY2025Mar 31, 2025-$772.00K-109.3%
Q4 FY2024Dec 31, 2024$801.00K-86.7%
Q3 FY2024Sep 30, 2024$1.13M-95.1%
Q2 FY2024Jun 30, 2024-$8.15M-126.9%
Q1 FY2024Mar 31, 2024$8.32M-79.2%
Q4 FY2023Dec 31, 2023$6.04M-77.2%
Q3 FY2023Sep 30, 2023$23.13M-36.0%
Q2 FY2023Jun 30, 2023$30.28M-22.6%
Q1 FY2023Mar 31, 2023$39.97M-4.3%
Q4 FY2022Dec 31, 2022$26.52M-22.1%
Q3 FY2022Sep 30, 2022$36.16M-13.9%
Q2 FY2022Jun 30, 2022$39.11M-16.7%
Q1 FY2022Mar 31, 2022$41.78M+1.7%
Q4 FY2021Dec 31, 2021$34.02M+21.5%
Q3 FY2021Sep 30, 2021$41.98M+21.9%
Q2 FY2021Jun 30, 2021$46.96M+114.1%
Q1 FY2021Mar 31, 2021$41.06M+122.2%
Q4 FY2020Dec 31, 2020$27.99M+40.8%
Q3 FY2020Sep 30, 2020$34.45M+116.7%
Q2 FY2020Jun 30, 2020$21.94M+2.6%
Q1 FY2020Mar 31, 2020$18.48M-11.0%
Q4 FY2019Dec 31, 2019$19.88M+27.0%
Q3 FY2019Sep 30, 2019$15.90M+15.4%
Q2 FY2019Jun 30, 2019$21.38M+51.3%
Q1 FY2019Mar 31, 2019$20.75M+69.8%
Q4 FY2018Dec 31, 2018$15.65M+114.2%
Q3 FY2018Sep 30, 2018$13.78M+106.1%
Q2 FY2018Jun 30, 2018$14.13M+86.4%
Q1 FY2018Mar 31, 2018$12.22M+98.9%
Q4 FY2017Dec 31, 2017$7.31M+77.6%
Q3 FY2017Sep 30, 2017$6.69M–
Q2 FY2017Jun 30, 2017$7.58M–
Q1 FY2017Mar 31, 2017$6.15M–
Q4 FY2016Dec 31, 2016$4.11M–

More Medifast figures

See a number that looks wrong?